Delivery Order SPE2DB20D1050-SPE2DB25FH92V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xcopri 150 mg tablets (30-count units) under a firm fixed price contract valued at $1,393.98. This non-set-aside, competitively awarded delivery order has an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item procurement of this neurological...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xcopri 100 mg tablets in quantities of 30 units, with a ceiling value of $2,357.92 and an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilized firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) valued at $1,037.97. This firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Xcopri 100 mg tablets in a quantity of 30 units, with a contract ceiling value of $2,338.28. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,221.54 to AmerisourceBergen Drug Corp for the supply of Xcopri 100 mg tablets (30-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Xcopri 150 mg tablets (30-count units) with a ceiling value of $1,178.96. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was competitively awarded without set-aside designation and is scheduled for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count units) on May 20, 2025, with an ultimate completion date of May 21, 2025. This firm fixed-price delivery order, valued at $1,768.44, represents a non-set-aside competitive award and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract is issued as a child order under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Xcopri 150 mg tablets (30-count units) with a ceiling value of $1,800.99. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by September 8, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xcopri 50 mg tablets in a quantity of 30 units, valued at $7,073.76. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $3,927.06 delivery order to AmerisourceBergen Drug Corp for Xcopri 200 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract is structured as a firm fixed price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xcopri is a prescription anticonvulsant medication used in epilepsy treatment, reflecting the Defense...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH92VDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Xcopri 150 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with a ceiling value of $10,379.68 and an ultimate completion date of September 23, 2025. The contract was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xcopri is a neurological medication used in the treatment of seizure disorders, reflecting the company's role as a critical pharmaceutical distributor for federal military and healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent success in fulfilling competitively awarded delivery orders across multiple therapeutic domains, positioning it as a major vendor within the DLA's medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 9/22/25 |